BSE filing, NSE: CITURGIBIO. Summary written from the filing by ALFA Finder's alert engine.
Citurgia Biochemicals Ltd: key numbers
- Share price
- ₹102.45
- Market cap
- ₹1,353 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -1827.2×Sector 34.5×
- Promoter holding
- 99.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Citurgia Biochemicals Ltd
All →Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Ltd has submitted its quarterly shareholding pattern disclosure as required under Regulation 31(1)(b) of the SEBI Listing Regulations.
Citurgia Biochemicals Board Meeting Date
Citurgia Biochemicals announced a board meeting on October 6, 2026, to discuss scheduling the 51st Annual General Meeting and approving associated reports.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Limited received approval from the Registrar of Companies for a one-month extension to hold its 51st Annual General Meeting by October 31, 2026.
Citurgia Biochemicals Management Change
Citurgia Biochemicals submitted the resignation letter of CS Yatendra Kumar, effective 24 July 2026. The filing rectifies a prior omission of the letter under Regulation 30 (LODR).
Citurgia Biochemicals Q1 FY27 Results: Net Loss of ₹0.1 Cr, Loss Widens
Citurgia Biochemicals Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Citurgia Biochemicals Board Meeting Date
Citurgia Biochemicals Limited will hold a board meeting on August 12, 2026, to consider and approve standalone unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.